Dipali A.

Associate Director, Pharmacovigilance at Stemline Therapeutics Inc - New York, NY, US

Dipali A.'s Contact Details
HQ
646-502-2310
Location
Company
Stemline Therapeutics Inc
Dipali A.'s Company Details
Stemline Therapeutics Inc logo, Stemline Therapeutics Inc contact details

Stemline Therapeutics Inc

New York, NY, US • 100 - 249 Employees
BioTech/Drugs

Stemline is a commercial-stage biopharmaceutical company committed to applying our scientific leadership and commercial expertise to transform the lives of patients with cancer.ELZONRIS a targeted therapy directed to CD123, is FDA-approved and commercially available in the U.S. for the treatment of adult and pediatric patients, two years and older, with BPDCN. In Europe, a marketing authorization application (MAA) is under review by the European Medicines Agency (EMA).Inspired by the goal to improve outcomes for patients with unmet medical needs, Stemline is driven to discover and develop innovative therapeutics for the treatment of cancer. Currently our clinical-stage product candidates in include ELZONRIS, SL-701 and SL801.

B2B Biotechnology Healthcare Marketing Medical Diagnostics Pharmaceuticals BioTech/Drugs Commercial Physical Research
Details about Stemline Therapeutics Inc
Frequently Asked Questions about Dipali A.
Dipali A. currently works for Stemline Therapeutics, Inc..
Dipali A.'s role at Stemline Therapeutics, Inc. is Associate Director, Pharmacovigilance.
Dipali A.'s email address is ***@stemline.com. To view Dipali A.'s full email address, please signup to ConnectPlex.
Dipali A. works in the Biotechnology industry.
Dipali A.'s colleagues at Stemline Therapeutics Inc are Ross Lindsay, Megan Fishwick, Cidney Choi, Jared Pendergrass, Danielle PharmD, Ingrid Zeltins, David Gionco and others.
Dipali A.'s phone number is 646-502-2310
See more information about Dipali A.